PA SHUN INTERNATIONAL HOLDINGS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.044 HKD | +4.76% |
|
-8.33% | +41.94% |
| 04-03 | Pa Shun International Holdings Names Chairman, CEO | MT |
| 04-02 | Pa Shun International Holdings Limited Announces Board Appointments | CI |
| Sales 2021 | 85.91M 11.86M 92.8M 946M | Sales 2022 | 71.78M 9.91M 77.54M 791M | Capitalization | 77.99M 10.77M 84.24M 859M |
|---|---|---|---|---|---|
| Net income 2021 | -330M -45.55M -356M -3.63B | Net income 2022 | -43M -5.94M -46.45M -474M | EV / Sales 2021 | 2.06 x |
| Net Debt 2021 | 96.74M 13.35M 104M 1.07B | Net Debt 2022 | 107M 14.74M 115M 1.18B | EV / Sales 2022 | 2.57 x |
| P/E ratio 2021 |
-0.24
x | P/E ratio 2022 |
-1.8
x | Employees | 90 |
| Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 45.43% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +4.76% | ||
| 1 week | -8.33% | ||
| Current month | -12.00% | ||
| 1 month | -10.20% | ||
| 3 months | -33.33% | ||
| 6 months | -13.73% | ||
| Current year | +41.94% |
1 week
0.04
0.05
1 month
0.040.06
Current year
0.030.10
1 year
0.030.10
3 years
0.030.12
5 years
0.030.42
10 years
0.032.48
| Managers | Title | Age | Since |
|---|---|---|---|
| Corporate Secretary | - | 30/09/23 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Khie Liem Khor
BRD | Director/Board Member | 56 | 09/03/23 |
Hong Bing Yuan
CHM | Chairman | 45 | 27/03/23 |
Yan Li
BRD | Director/Board Member | 46 | 09/03/23 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/04/24 | 0.044 | +4.76% | 90 000 |
| 26/04/24 | 0.042 | -10.64% | 12,000 |
| 25/04/24 | 0.047 | +9.30% | 658,000 |
| 24/04/24 | 0.043 | -10.42% | 394,000 |
| 23/04/24 | 0.048 | 0.00% | 0 |
Delayed Quote Hong Kong S.E., April 29, 2024 at 02:44 am
More quotes
Pa Shun International Holdings Limited, formerly Pa Shun Pharmaceutical International Holdings Limited is a Hong Kong-based investment holding company principally engaged in pharmaceutical businesses. The Company operates through three segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceuticals to wholesalers, pharmacy stores, hospitals and other medical institutions, among others. Self-operated Retail Pharmacies segment is mainly engaged in pharmaceutical and healthcare products, cosmetic products and daily necessities in self-operated retail pharmacies. Pharmaceutical Manufacturing segment is engaged in the sales of pharmaceutical products manufactured by the Company.
Sector
Pharmaceuticals
Calendar
28/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +41.94% | 7.91M | |
| +17.35% | 71.39B | |
| +2.39% | 25.1B | |
| -1.22% | 8.59B | |
| +6.69% | 8.19B | |
| -20.96% | 7.91B | |
| +0.49% | 4.54B | |
| +17.12% | 4.31B | |
| -2.61% | 3.86B | |
| +22.08% | 3.64B |
- Stock Market
- Equities
- 574 Stock
